# Americas Carmart Inc: financial statements, quarterly

CRMT · Nasdaq · CIK 799850 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Apr 30

Pages: [Overview](/companies/crmt.md) · [Financials](/companies/crmt/financials.md) · [Filings](/companies/crmt/filings.md) · [Insiders](/companies/crmt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/crmt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q4 FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [300](/filings/0001171843-24-006828.md) | [240](/filings/0001628280-25-011664.md) | [307 d](/filings/0001628280-26-048191.md) | [287](/filings/0000799850-25-000006.md) | [286](/filings/0001628280-25-056054.md) | [263](/filings/0001628280-26-017369.md) | [310 d](/filings/0001628280-26-048191.md) | [276](/filings/0001628280-26-061105.md) | [286](/filings/0001628280-25-056054.md) | [223](/filings/0001628280-26-017369.md) | [243 d](/filings/0001628280-26-048191.md) | [89.9](/filings/0001628280-26-061105.md) |
| Cost of revenue | $m | [197](/filings/0001171843-24-006828.md) | [158](/filings/0001628280-25-011664.md) | [198 d](/filings/0001628280-26-048191.md) | [187](/filings/0000799850-25-000006.md) | [173](/filings/0001628280-25-056054.md) | [169](/filings/0001628280-26-017369.md) | [197 d](/filings/0001628280-26-048191.md) | [175](/filings/0001628280-26-061105.md) | [179](/filings/0001628280-25-056054.md) | [143](/filings/0001628280-26-017369.md) | [167 d](/filings/0001628280-26-048191.md) | [70.3](/filings/0001628280-26-061105.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [44.9](/filings/0001171843-24-006828.md) | [43.6](/filings/0001628280-25-011664.md) | [44.5 d](/filings/0001628280-26-048191.md) | [46.7](/filings/0000799850-25-000006.md) | [47.4](/filings/0001628280-25-056054.md) | [46.5](/filings/0001628280-26-017369.md) | [48.3 d](/filings/0001628280-26-048191.md) | [51.4](/filings/0001628280-26-061105.md) | [57.2](/filings/0001628280-25-056054.md) | [51.5](/filings/0001628280-26-017369.md) | [47.6 d](/filings/0001628280-26-048191.md) | [51.6](/filings/0001628280-26-061105.md) |
| Interest expense | $m | [16.6](/filings/0001171843-24-006828.md) | [16.7](/filings/0001171843-24-001273.md) | [17.8 d](/filings/0001171843-24-003950.md) | [18.3](/filings/0001171843-24-005205.md) | [18.0](/filings/0001171843-24-006828.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(8.1)](/filings/0001171843-24-006828.md) | [(1.8)](/filings/0001628280-25-011664.md) | [0.2 d](/filings/0001628280-26-048191.md) | [(0.2)](/filings/0000799850-25-000006.md) | [2.0](/filings/0001628280-25-056054.md) | [1.2](/filings/0001628280-26-017369.md) | [1.8 d](/filings/0001628280-26-048191.md) | [(1.7)](/filings/0001628280-26-061105.md) | [(5.0)](/filings/0001628280-25-056054.md) | [40.0](/filings/0001628280-26-017369.md) | [(2.2) d](/filings/0001628280-26-048191.md) | [0.1](/filings/0001628280-26-061105.md) |
| Net income | $m | [(27.5)](/filings/0001628280-25-011664.md) | [(8.5)](/filings/0001628280-25-011664.md) | [0.4 d](/filings/0001628280-26-048191.md) | [(1.0)](/filings/0001628280-26-017369.md) | [5.1](/filings/0001628280-26-017369.md) | [3.2](/filings/0001628280-26-017369.md) | [10.6 d](/filings/0001628280-26-048191.md) | [(5.7)](/filings/0001628280-26-061105.md) | [(22.5)](/filings/0001628280-26-017369.md) | [(76.7)](/filings/0001628280-26-017369.md) | [(34.2) d](/filings/0001628280-26-048191.md) | [(69.0)](/filings/0001628280-26-061105.md) |
| Diluted EPS | $ per share | [(4.30)](/filings/0001171843-24-006828.md) | [(1.34)](/filings/0001628280-25-011664.md) | not reported | [(0.15)](/filings/0000799850-25-000006.md) | [0.61](/filings/0001628280-25-056054.md) | [0.37](/filings/0001628280-26-017369.md) | not reported | [(0.69)](/filings/0001628280-26-061105.md) | [(2.71)](/filings/0001628280-25-056054.md) | [(9.25)](/filings/0001628280-26-017369.md) | not reported | [(8.28)](/filings/0001628280-26-061105.md) |
| Basic EPS | $ per share | [(4.30)](/filings/0001171843-24-006828.md) | [(1.34)](/filings/0001628280-25-011664.md) | not reported | [(0.15)](/filings/0000799850-25-000006.md) | [0.62](/filings/0001628280-25-056054.md) | [0.38](/filings/0001628280-26-017369.md) | not reported | [(0.69)](/filings/0001628280-26-061105.md) | [(2.71)](/filings/0001628280-25-056054.md) | [(9.25)](/filings/0001628280-26-017369.md) | not reported | [(8.28)](/filings/0001628280-26-061105.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2024-01-31) | period not labelled (2024-03-31) | FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [4.2](/filings/0001171843-24-001273.md) | not reported | [5.5](/filings/0001628280-25-039026.md) | [4.7](/filings/0001171843-24-005205.md) | [8.0](/filings/0001171843-24-006828.md) | [8.5](/filings/0001628280-25-011664.md) | [9.8](/filings/0001628280-26-048191.md) | [9.7](/filings/0000799850-25-000006.md) | [122](/filings/0001628280-25-056054.md) | [118](/filings/0001628280-26-017369.md) | [47.0](/filings/0001628280-26-061105.md) | [27.5](/filings/0001628280-26-061105.md) |
| Total assets | $m | [1,467](/filings/0001171843-24-001273.md) | not reported | [1,478](/filings/0001628280-25-039026.md) | [1,531](/filings/0001171843-24-005205.md) | [1,575](/filings/0001171843-24-006828.md) | [1,607](/filings/0001628280-25-011664.md) | [1,606](/filings/0001628280-26-048191.md) | [1,608](/filings/0000799850-25-000006.md) | [1,718](/filings/0001628280-25-056054.md) | [1,627](/filings/0001628280-26-017369.md) | [1,417](/filings/0001628280-26-061105.md) | [1,206](/filings/0001628280-26-061105.md) |
| Total liabilities | $m | [998](/filings/0001171843-24-001273.md) | not reported | [1,006](/filings/0001628280-25-039026.md) | [1,060](/filings/0001171843-24-005205.md) | [1,021](/filings/0001171843-24-006828.md) | [1,049](/filings/0001628280-25-011664.md) | [1,037](/filings/0001628280-26-048191.md) | [1,043](/filings/0000799850-25-000006.md) | [1,162](/filings/0001628280-25-056054.md) | [1,147](/filings/0001628280-26-017369.md) | [971](/filings/0001628280-26-061105.md) | [829](/filings/0001628280-26-061105.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [469](/filings/0001171843-24-001273.md) | [471](/filings/0001628280-25-011664.md) | [471](/filings/0001628280-25-039026.md) | [471](/filings/0001171843-24-005205.md) | [554](/filings/0001171843-24-006828.md) | [558](/filings/0001628280-25-011664.md) | [569](/filings/0001628280-26-048191.md) | [565](/filings/0000799850-25-000006.md) | [555](/filings/0001628280-25-056054.md) | [479](/filings/0001628280-26-017369.md) | [446](/filings/0001628280-26-061105.md) | [376](/filings/0001628280-26-061105.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q4 FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(30.7) d](/filings/0001171843-24-006828.md) | [13.0 d](/filings/0001628280-25-011664.md) | [(10.7) d](/filings/0001628280-26-048191.md) | [(15.0)](/filings/0000799850-25-000006.md) | [(22.2) d](/filings/0001628280-25-056054.md) | [(30.8) d](/filings/0001628280-26-017369.md) | [19.2 d](/filings/0001628280-26-048191.md) | [(5.9)](/filings/0001628280-26-061105.md) | [9.1 d](/filings/0001628280-25-056054.md) | [(5.9) d](/filings/0001628280-26-017369.md) | [67.7 d](/filings/0001628280-26-048191.md) | [80.1](/filings/0001628280-26-061105.md) |
| Capital expenditure | $m | [0.8 d](/filings/0001171843-24-006828.md) | [2.7 d](/filings/0001628280-25-011664.md) | [1.3 d](/filings/0001628280-26-048191.md) | [1.0](/filings/0000799850-25-000006.md) | [1.4 d](/filings/0001628280-25-056054.md) | [0.8 d](/filings/0001628280-26-017369.md) | [0.8 d](/filings/0001628280-26-048191.md) | [0.5](/filings/0001628280-26-061105.md) | [0.8 d](/filings/0001628280-25-056054.md) | [0.3 d](/filings/0001628280-26-017369.md) | [0.3 d](/filings/0001628280-26-048191.md) | [0.1](/filings/0001628280-26-061105.md) |
| Dividends paid | $m | [0.0 d](/filings/0001171843-24-006828.md) | [0.0 d](/filings/0001628280-25-011664.md) | [0.0 d](/filings/0001628280-25-039026.md) | [0.0](/filings/0000799850-25-000006.md) | [0.0 d](/filings/0001628280-25-056054.md) | [0.0 d](/filings/0001628280-26-017369.md) | [0.0 d](/filings/0001628280-25-039026.md) | [0.0](/filings/0001628280-26-061105.md) | [0.0 d](/filings/0001628280-25-056054.md) | [0.0 d](/filings/0001628280-26-017369.md) | not reported | [0.0](/filings/0001628280-26-061105.md) |
| Share repurchases | $m | [0.0 d](/filings/0001171843-24-006828.md) | [0.3 d](/filings/0001628280-25-011664.md) | [0.0 d](/filings/0001628280-26-048191.md) | [0.0](/filings/0000799850-25-000006.md) | [0.4 d](/filings/0001628280-25-056054.md) | [0.0 d](/filings/0001628280-26-017369.md) | [0.0 d](/filings/0001628280-26-048191.md) | [0.1](/filings/0001628280-26-061105.md) | [0.2 d](/filings/0001628280-25-056054.md) | [0.0 d](/filings/0001628280-26-017369.md) | [(0.0) d](/filings/0001628280-26-048191.md) | [0.0](/filings/0001628280-26-061105.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-10-31) | Q3 FY2023 (2023-01-31) | Q1 FY2024 (2023-07-31) | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [6,548](/filings/0001171843-23-007512.md) | [6,537](/filings/0001171843-24-001273.md) | [6,635](/filings/0001171843-24-005205.md) | [6,386](/filings/0001171843-24-006828.md) | [6,393](/filings/0001628280-25-011664.md) | [6,397](/filings/0000799850-25-000006.md) | [8,292](/filings/0001628280-25-056054.md) | [8,413](/filings/0001628280-26-017369.md) | [8,274](/filings/0001628280-26-061105.md) | [8,283](/filings/0001628280-25-056054.md) | [8,297](/filings/0001628280-26-017369.md) | [8,330](/filings/0001628280-26-061105.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 8,338,478 at 2026-09-09, from the cover of the [10-Q filed 2026-09-09](/filings/0001628280-26-061105.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.